Furthermore, elevated LDLapoB/LDL‐c ratio have been reported to associate with increased cardiovascular mortality in patients referred for coronary angiography (Silbernagel et al., 2022), and levels of apoB are increasingly recognized as the strongest risk markers for cardiovascular disease (Sniderman et al., 2024). This evidence concerns the gene APOB and cardiovascular disorder.